This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Human in silico trials for parametric computational fluid dynamics investigation of cerebrospinal fluid drug delivery: impact of injection location, injection protocol, and physiology
Fluids and Barriers of the CNS Open Access 28 January 2022
-
State of play and clinical prospects of antibody gene transfer
Journal of Translational Medicine Open Access 07 June 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morrison, C. $1-million price tag set for Glybera gene therapy. Nat Biotechnol 33, 217–218 (2015). https://doi.org/10.1038/nbt0315-217
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0315-217
This article is cited by
-
Engineered AAV8 capsid acquires heparin and AVB sepharose binding capacity but has altered in vivo transduction efficiency
Gene Therapy (2023)
-
Human in silico trials for parametric computational fluid dynamics investigation of cerebrospinal fluid drug delivery: impact of injection location, injection protocol, and physiology
Fluids and Barriers of the CNS (2022)
-
Multifunctional nucleic acid nanostructures for gene therapies
Nano Research (2018)
-
State of play and clinical prospects of antibody gene transfer
Journal of Translational Medicine (2017)
-
Biogen and UPenn join forces to commercialize gene therapies
Nature Biotechnology (2016)